Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levels

BACKGROUND: Optimization of chemotherapy effectiveness in metastatic colorectal cancers (mCRC) is a major endpoint to enhance the possibility of curative intent surgery. FOLFIRI3 has shown promising results as second-line chemotherapy for mCRC patients previously exposed to oxaliplatin. The clinical...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kim, Stefano, Dobi, Erion, Jary, Marine, Monnien, Franck, Curtit, Elsa, NGuyen, Thierry, Lakkis, Zaher, Heyd, Bruno, Fratte, Serge, Cléau, Denis, Lamfichekh, Najib, Nerich, Virginie, Guiu, Boris, Demarchi, Martin, Borg, Christophe
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3877948/
https://ncbi.nlm.nih.gov/pubmed/24373251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-611
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars